Health Care: Drugs

United Therapeutics Corp (UTHR: NASDAQ)

$126.49 n/a | n/a%
12/02/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 126.49
52 Week High 164.04
52 Week Low 97.52
Avg. Daily Vol. (Mil) 0.58
Beta (3 year) 1.43
Share Related Items
Mkt Cap (Mil) 5,365.13
Shares Out (Mil) 42.42
Float (Mil) 37.09
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.00
Current Ratio 4.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 8.50
Price/Sales 3.36
Price/Book 2.92
Price/Cash Flow 7.20
Per Share Data
Earnings 14.87
Sales 37.60
Book Value 43.35
Cash Flow 17.46
Business Summary
United Therapeutics Corp is a biotechnology company. The Company is engaged in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.
General Information
1040 Spring Street
Silver Spring, MD 20910
www.unither.com
Industry : Drugs
Sector: Health Care
Employees: 750
CEO: Martine A. Rothblatt,PhD
Short Interest
Current Month (Mil) 8.62
Previous Month (Mil) 8.36
Short Interest Ratio (Days) 12.80
Management Effectiveness
Return on Equity 38.50
Return on Assets 31.20
Return on Investments 38.50
Profitability
Gross Margin 97.70
EBIT Margin 65.70
Profit Margin 44.40

Portfolios with UTHR

Latest UTHR Headlines from TheStreet

More Financial News for UTHR

Press Releases for UTHR

See All Press Releases

Partner Headlines for UTHR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter